Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Drug-Related Side Effects and Adverse Reactions × Telbivudine × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1 Hepatitis B 1 Drug-Related Side Effects and Adverse Reactions 1 Carcinoma, Hepatocellular 1

Interventions

Drug Therapy 3 uridine triacetate 1 camrelizumab 1 Telbivudine 1 Tegafur 1 Surgical Procedures, Operative 1 Radiotherapy 1 Pharmaceutical Services 1 Octreotide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Gemcitabine 1 Fluorouracil 1 Fecal Microbiota Transplantation 1 Docetaxel 1 Dihydrouracil Dehydrogenase (NADP) 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01102335 2010-04-13

TACEHBV

Fudan University

Phase 4 Unknown

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Liver Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡